The Norwegian life sciences industry performed well in 2022 compared to the years before 2021 (2018 – 2020), raising USD 38 million in private equity investments according to Biotechgate data. However, it could not compete with the record level of venture financing in 2021 (USD 65 million). Cytovation ASA secured the largest round in 2022. … Continue reading Norway Life Science Trend Analysis 2023
